Support Alert

Chloroquine and Hydroxychloroquine not licensed for coronavirus (COVID-19) treatment

MHRA have issued a press release around recent media reports that have suggested that chloroquine can protect patients from coronavirus or treat COVID-19, the illness caused by a coronavirus. Chloroquine and hydroxychloroquine are not licensed to treat COVID-19 related symptoms or prevent infection.

Clinical trials are ongoing to test chloroquine and hydroxychloroquine as an agent in the treatment of COVID-19 or to prevent COVID-19 infection. These clinical trials are still not completed, so no conclusions have been reached on the safety and effectiveness of this medicine to treat or prevent COVID-19.

Until we have clear, definitive evidence these treatments are safe and effective for the treatment of COVID-19, they should only be used for this purpose within a clinical trial

Further details of the press release can be found on the MHRA website


Loading...

Renew for 2022

Your dedication to patient care has made us proud during 2021.

That's why you can count on us to represent your interests and support your efforts every step of the way in 2022.

RENEW YOUR MEMBERSHIP TODAY